It’s about timing IMO. IPIX was once a $500M MC company riding on positive B-ABSSSI data and QIDP news. Now Sorrento is riding on their COVID-19 news. Just last week their MC was ~$500M. Besides STI-1499, they have ~$22M in cash, 10 ongoing trials in all three phases, and 1 NDA submission. No doubt IPIX’s MC will be much higher if they have $20M+ cash on hand.